Clinical trial
Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the…
NCT00197184 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00197184 |
|---|---|
| Title | Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared |
| Official title | Evaluate the Persistence of Immune Response of GSK Biologicals' Twinrix™ Vaccine, Administered According to a 0,6 Month Schedule and a 0,1,6 Month Schedule, in Healthy Children Aged Between 1-11 Years at the Time of First Vaccine Dose |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B, Hepatitis A |
| Intervention type | Biological |
| Interventions | Twinrix™ Adult, Twinrix™ Junior |
| Enrollment | 276 |
| Start date | Nov 1, 2003 |
| Primary completion | Mar 10, 2004 |
| Completion | Mar 10, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 20, 2018 |
| Countries | Australia, Belgium, Spain |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: